DPET is a rapidly growing division focused on collaborative clinical and translational research projects, with a special emphasis on developing world-class programs in pharmacogenomics, quantitative pharmacology, and experimental therapeutics. Current research centers around the following therapeutic areas: oncology, cardiovascular, HIV, and gastroenterology/hepatology.

Our members include:

• Twenty-five faculty members
• Twenty-two graduate students
• Sixteen clinical fellows
• Six postdoctoral research scientists

The Division houses six Centers and Programs, including:

• The Institute for Pharmacogenomics and Individualized Therapy (IPIT)
• Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Laboratory
• The Good Laboratory Practice Analytical Facility
• The UNC Cellular Metabolism and Transport-Core

The Division’s graduate program focuses on developing translational research skills that facilitate evaluation of the mechanisms of disease processes and drug therapy. Students utilize preclinical models and conduct patient-oriented research to evaluate mechanisms of disposition, efficacy, and toxicity of therapeutic agents.

Postgraduate research opportunities are provided through a variety of fellowship programs, including:

• Academic:

• Heart Failure Pharmacotherapy
• HIV Pharmacology
• Oncology

• Industry sponsored fellowships:

• Clinical Research and Drug Development
• Pharmacokinetic/Pharmacodynamic Research